Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mozart: Levetiracetam in Refractory Focal Epilepsy
NCT01392768Phase 3Completed
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Jan 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Focal Epilepsy (FE) comparing Levetiracetam with Placebo (2 arms). Primary endpoint: Partial onset seizure frequency per week at 24 weeks. Started Jan 2013; status: completed.
02
Drugs
levetiracetam
03
Conditions
Focal Epilepsy (FE)
Beyond the preview
Go deeper on NCT01392768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01392768.